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Abstract
The X-ray structures of the channel-forming colicins Ia and N, and endoribonucleolytic colicin E3, as well as of the channel domains of
colicins A and E1, and spectroscopic and calorimetric data for intact colicin E1, are discussed in the context of the mechanisms and pathways
by which colicins are imported into cells. The extensive helical coiled-coil in the R domain and internal hydrophobic hairpin in the C domain
are important features relevant to colicin import and channel formation. The concept of outer membrane translocation mediated by two
receptors, one mainly used for initial binding and second for translocation, such as BtuB and TolC, respectively, is discussed. Helix
elongation and conformational flexibility are prerequisites for import of soluble toxin-like proteins into membranes. Helix elongation
contradicts suggestions that the colicin import involves a molten globule intermediate. The nature of the open-channel structure is discussed.
Published by Elsevier Science B.V.
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1. X-ray structures of colicins and their C-terminal
domains; what do they tell us about the mechanism of
colicin insertion into and through the cell envelope?
1.1. Intact colicins (Fig. 1A–C)
Two structures of an intact or almost intact colicin have
been solved by X-ray diffraction of three-dimensional crys-
tals: (i) The structure of residues 23–39 and 83–624 of the
626 residue pore-forming colicin Ia (‘‘B-type,’’ translocated
by the TonB system) has been resolved to 3.0-A˚ resolution
(Fig. 1A [1]). (ii) Residues 84–551 of the 551-residue non-
pore forming ‘‘’’A-type’’ (translocated by the TolA system)
endoribonuclease colicin E3 have been solved to 3.0 A˚;
approximately half of the N-terminal translocation domain
(T, in green, Fig. 1) was not resolved (Fig. 1B [2]). The region
of colicin E3 drawn in yellow in Fig. 1B corresponds to its
immunity protein [2]. (iii) In addition, 292 residues, 93–385,
of a 321-residue chymotryptic fragment of the smaller 387-
residue pore-forming colicin N, provide a 3.1-A˚ structure that
contains the globular channel domain (C, in blue, Fig. 1C),
but is missing the T domain and a substantial part of the N-
terminal region of the R domain (in red, Fig. 1 [3]).
Colicin Ia forms an elongate 210-A˚ structure with
spatially well-separated domains (C and T, Fig. 1A) that
are responsible for the functions of channel formation (C) in
the cytoplasmic membrane and translocation (T) across the
periplasmic space. The prominent elongate nature of the
structure is a consequence of an extended 160-A˚ long
coiled-coil structure consisting of residues 176–282 and
359–467 (red, Fig. 1A). In colicin E3, a somewhat shorter
but still quite extended (100 A˚) anti-parallel ‘‘Alacoil’’
helical coiled-coil structure, in which every seventh residue
is an alanine in the core of the coiled-coil, was subsequently
described in the structure of colicin E3 [2]. By analogy with
colicin Ia, and the R-domain coiled-coil structure inferred
from calorimetry and circular dichroism (CD) for colicin E1
[4], the coiled-coil spanning residues 320–440 of colicin E3
was proposed to contain the R-domain function [2]. The
135-residue colicin E3 peptide, Thr313–Asn447, was sub-
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sequently found to have a high affinity for the isolated BtuB
receptor and to retain its coiled-coil nature [5].
1.2. The domain concept
Separable or distinguishable domains in the colicins can
be defined by two general criteria: (a) function and (b)
structure (e. g., Fig. 1D). The definition of functional
domains, mostly utilizing a combination of genetic, micro-
biological, and biochemical analysis [6], historically pre-
ceded those defined by structure.
Even though relatively compact domains defined by X-
ray structure (e.g., green, red, and blue domains, Fig. 1) can
often be associated with functional domains, this association
is not always unambiguous. Thus, (a) in colicin E3, it is not
clear a priori, whether the short helix (residues 293–313, in
gray, Fig. 1B) that is oriented at a sharp angle to the
extended coiled-coil (red) should be associated with the T-
and/or R domains that it connects; (b) in colicin Ia, the N-
terminal 50-residue (176–225) segment of the long helix
spanning residues 176–282 (red, Fig. 1A) was originally
associated with the two anti-parallel a-helices of the T
domain [1]. However, because of the continuity of this long
helix, and the apparently limited contact of its N-terminal 50
residues with the two anti-parallel helices of the T domain
(green, Fig. 1), we have designated the entire 176–282 helix
as part of the receptor-binding (R) domain along with the
rest of the extended coiled-coil (red, Fig. 1A). One caveat to
this designation is that the degree of interaction of the N
terminus of the 176–282 helix with the T domain is some-
what uncertain because only 17 of the first 82 residues in the
T domain have been resolved.
The colicin structural domains can be distinguished by:
(i) selective proteolysis and (ii) differential scanning calo-
rimetry (DSC). The relatively high proteolytic sensitivity of
the T domain has allowed isolation of C and R-C domains
(e.g., Ref. [7,8]). Intact colicin E1 and its T, R, and C
domains melt cooperatively as separate units with defined
heat capacities and distinct melting (Tm) temperatures (Fig.
2, [4]), because they are separately packed by van der
Waals, H-bond, and electrostatic interactions. The structural
and functional definitions of colicin domains generally
overlap, but the T or R domains may contain multiple
functional regions or sites, as shown in the 34-residue N-
terminal TolA and 140-residue TolC [9] subdomains in the
T domain of colicin E1 (Fig. 1D).
1.3. R domain
Considering the similarity of the length of the coiled-coil
with the approximate width of the periplasmic space, it was
proposed that the function of the major part of the 160-A˚
Fig. 1. Ribbon diagrams describing the atomic structures of (A) colicin Ia [1], (B) colicin E3 [2], and (C) colicin N [3], derived from X-ray diffraction analysis
of 3-D crystals. The regions corresponding to R (red), T (green), and C (blue) domains are shown. Residues 1–22 and 40–82 in colicin Ia, 1–66 in colicin N,
and 1–83 in colicin E3, respectively, were not resolved; figure generated by MOLSCRIPT [67]. (D) Functional domain organization of the 522-residue colicin
E1. The colicin E1 R domain was predicted from proteolytic [8] and cyanogen bromide [68] cleavage, and was verified by combined CD and DSC analysis [4].
N termini of proteolytic fragments of E1 P342 and P178 are indicated by asterisks.
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coiled-coil of colicin Ia (residues 176–282 and 359–467)
would be to bridge the periplasmic space as part of the
mechanism of translocation across it [1]. In this proposal,
only a 104-residue region at the tip of the coiled-coil,
consisting of an amphipathic two-stranded h-hairpin folded
around the tip-terminal helix of the coiled-coil, was pro-
posed to be involved in binding to the colicin Ia Cir
receptor. The R domain of colicin N was proposed to consist
of a 65-residue, 97–161, six-stranded h-strand wrapped
around the C-terminal end of a 45-residue extended helix
(65 A˚) that was proposed to be part of the pore-forming
domain [3].
Regarding colicin Ia, comparison of its structure with
genetic and function analysis of the domain structure of the
pore-forming colicins implied that the whole coiled-coil
might be a good fit to the receptor binding R domain.
Subsequent studies of the minimum receptor binding
domain in the A-type colicins E9 and E3 that inhibit
Fig. 2. Differential scanning calorimetry and circular dichroism melting curves of colicin E1 and its three structural domains. (A) Deconvolution analysis of the
excess heat capacity function of intact colicin E1. Broken lines represent the fitting of the experimental data (green) to three transitions, with the sum of
individual transitions shown as black solid lines. (B) Thermal scanning of CD signals of intact E1, P342 and P178 at 222 nm, 23 jC. Modified from Ref. [4].
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intracellular protein synthesis have indicated that a large
part of the coiled-coil, but perhaps only its distal half, might
be necessary for recognition and effective binding to the
receptor (vide infra, Sections 3.3–3.4). The coiled-coil
nature of the receptor domain in the structure of intact
colicins Ia and E3 implies that this is a necessary structure
motif for interaction with the receptor that initially seques-
ters the colicin (vide infra). In the case of colicin N, only
one extended helix can be seen (Fig. 1C), which is only
about 65 A˚ in length. The second helix of the coiled-coil
may be missing in the colicin N structure because of the use
of the chymotrypsin fragment. The markedly smaller length
of the extended helix or coiled–coil of colicin N is sugges-
tive of a mechanism that is different from those used by
colicins Ia, E3 and E9 for receptor binding and translocation
across the outer membrane and periplasmic space.
1.4. Coiled-coil nature of R domain of colicin E1
The presence of an extended coiled-coil structure as the
dominant feature of the colicin E1 R domain was inferred
from DSC and CD analysis of the stability and interactions
of the colicin E1 R, T, and C domains [4]. The cooperative
thermal melting of highly helical R domain of the colicin
E1 implies that it is similar in structure to the R domain of
colicin E3 defined by X-ray structure analysis [2]. The
highest and lowest enthalpies (DH) of denaturation of
colicin E1 were associated, respectively, with the central
R- and N-terminal T domain. The large DHR of the R
domain is ascribed to extensive hydrogen bond and van der
Waals interactions associated with the coiled-coil structure.
The steep temperature dependence of its stabilization
energy in the physiological range, its interactions with the
T domain that mutually stabilize both domains, and its
destabilizing interaction with the C domain, imply that the
R domain has a dominant role in determining the confor-
mation of the whole protein and individual domains. Its
very high (>90%) a-helical content, and highly cooperative
thermal melting detected by far-UV CD in the same
temperature range as the R-domain denaturation measured
by DSC, imply that the R-domain coiled-coil is a major
determinant of the structure of the colicin. The high
sensitivity of the R domain to environmental conditions
and the linkage of the coiled-coil helices to the T and C
domains indicate that the R domain could control confor-
mational changes of the T and C domains [4]. Unfolding of
the R-domain coiled-coil could trigger a sequence of events
involving sequential interactions with the BtuB and TolC
receptors that result in import of the C domain across the
outer membrane to the cytoplasmic membrane (vide infra,
Section 3).
1.5. T domain
The N-terminal T domain of colicin Ia contains the
‘‘TonB box’’ (E23–V27) necessary for translocation
across the periplasm as part of an antiparallel helix
bundle. The secondary structure motif contrasts with the
h-sheet ‘‘jellyroll’’ that forms most of the colicin E3 T-
domain. The colicin E3 T-domain contains in its N-
terminal region a DGSGW (D35–W39) Tol B—‘‘box’’
needed for translocation, and is glycine-rich (34 of 79
residues), accounting for the disorder in this region. A
possible reason for the difference in the T-domain struc-
tures of colicins Ia and E3 is that the immunity protein is
tightly bound to the T domain in the latter. The immunity
protein of the channel forming colicins is not attached to
the colicin and resides in the cytoplasmic membrane of
Col or Imm cells [10, 11]. The colicin E1 T-domain was
found to be marginally stable, and is significantly stabi-
lized by interactions with R and C domains. Its enthalpy
of melting, DHT = 320 kJ/mol is on the lower end of the
range for globular proteins, implying its structure is
flexible due to a poor network of intradomain van der
Waals and H-bond interactions [4]. This is in agreement
with the high sensitivity to proteolytic degradation of the
colicin E1 T-domain [8] and with the lack of resolution of
the N-terminal 22 residues of colicin Ia [1] and 83
residues of colicin E3 [2] in the electron density derived
from X-ray diffraction.
1.6. Structures of C-terminal channel domains
The soluble active (pore-forming) 20,000 molecular
weight domain of colicins A [12] and E1 [13] along with
the structures of these domains in the intact colicins Ia and
N have the characteristic signature of a 10 helix globule.
The average length of these helices is 13 residues, much
shorter than required (ca. 20 residues) to span the membrane
bilayer.
The two longest helices, VIII–IX, in the channel domain
form a hydrophobic helical hairpin in the apolar core of the
channel domains, a feature that is also found in the struc-
tures of the membrane-active domain of diphtheria toxin
[14] and of the apoptotic protein, BCl-XL (Fig. 3 [15]). This
suggests that the function of this hydrophobic hairpin
structure motif in membrane-active proteins is to provide a
membrane anchor after the initial interaction of the protein
with the membrane surface (vide infra). Thus, the mecha-
nism of interaction of the pore-forming colicin channel
domains may be a paradigm for membrane-active apoptotic
proteins.
1.7. Helix dipoles can be involved in stabilization of the
colicin E1 channel domain
CD and DSC analysis have shown the 178-residue
channel polypeptide, P178, to be more stable at low than
at high ionic strength (10 vs. 300 mM), implying a preva-
lence of attractive over repulsive interactions even at pH 2.5.
It is hard to explain such an effect by electrostatic attraction
between basic (27 residues in P178) and acidic (22 in P178)
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side chains, because at least 90% of the carboxyl groups are
protonated at pH 2.5. There are no anomalously titrated
carboxyl groups in the colicin E1 channel domain in
solution (S. Venyaminov and S. Zakharov, unpublished
data). It is inferred that attraction between basic side chains
and the negative carboxyl ends of helix dipoles provides the
stabilization.
Beyond the implied role of the buried helical hydro-
phobic hairpin as a potential membrane anchor, the structure
of the soluble channel domain provides few clues about the
mechanism of colicin insertion into the membrane. Rather,
the structure implies that the soluble structure must undergo
large conformational changes in order to accomplish the
insertion. The mechanism of membrane insertion of the C-
terminal channel-forming domain, and the properties of the
inserted channel, have been studied with defined synthetic
lipid membranes using liposomes and planar bilayer mem-
branes.
2. Studies with synthetic membranes; what do they tell
us about mechanism of insertion into the cytoplasmic
membrane?
2.1. Kinetics of initial steps in membrane interaction
The initial events associated with the enormous confor-
mational changes undergone by the insertion of colicin into
membranes have been studied through the interaction of the
178-residue C-terminal channel domain of colicin E1, P178,
with liposome membranes of defined lipid composition. The
interaction is triggered in vitro by utilizing an acidic pHf 4
to (a) create attractive electrostatic interactions between
cationic P178 (effective binding charge, + 7) and liposome
membranes with a near-physiological (30–40 mol%)
anionic lipid content [16,17], and (b) to facilitate unfolding
of the protein at the membrane surface [18]. The first-order
rate constants for the initial events of membrane interaction
Fig. 4. Pathway of the distinguishable structure transitions of P178 in the course of binding to the membrane surface and insertion into the bilayer. Rate
constants for defined steps are for pH 4.0, I = 0.1 M and 25 jC (modified from Ref. [20]).
Fig. 3. Ribbon diagram of (A) T-domain of diphtheria toxin [14], (B) channel domain of colicin E1 [12], and (C) BCl-XL [15]. Hydrophobic hairpin shown in
brown. Shell of hydrophilic helices is in blue.
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of the colicin E1 channel polypeptide, P178, which are
defined by stopped flow measurements of fluorescence
quenching, fluorescence resonance energy transfer (FRET),
and CD are: (i) membrane binding (k = 30F 5 s 1), (ii)
unfolding (13F 0.5 s 1; obtained by FRET with Trp424;
rate constants for other Trp in Ref. [19]), (iii) helix elonga-
tion (k = 9.0F 1.0 s 1), and (iv) insertion (k = 6.6F 0.5
s 1) [20]. The net result is an unfolding of the globular
channel domain into an extended flexible helical two dimen-
sional network in the 10–15-A˚-thick interfacial layer (Fig.
4). In addition, it is energetically favorable for helical units
to organize on the membrane surface as paired anti-parallel
helical dipoles in individual helical hairpins.
2.2. Prerequisites for protein import
2.2.1. Helix elongation
With an average length of 13 residues, the a-helices of
the colicin E1 channel domain are much too short to span
the membrane bilayer. One of the structure changes that
must occur upon membrane binding is an elongation of the
helices that will ultimately span the membrane. In fact, the
a-helices of P178 elongate upon membrane binding by
approximately 30% from 13 to 17 residues (Fig. 5 [21]),
as determined by CD and infrared spectroscopy, assuming
that membrane-bound P178 has the same number of helical
segments as in the soluble state. After the activation barrier
imposed by structural restraints is removed by the unfold-
ing, helix formation is favored thermodynamically in the
intermediate polarity environment of the membrane inter-
facial layer [22–24]. Helix elongation of a membrane-active
protein upon membrane binding is predicted to be a general
property of pore-forming toxins that must ultimately form a
trans-membrane structure in which at least four helices span
the membrane as a-helices with a length of 18–20 residues.
Another consequence of the helix extension is the increase
of the average dipole moment associated with the helices.
2.2.2. Conformational flexibility
The models for P178 in the initial surface-bound state
and the final membrane-inserted open channel state (Fig.
6A–C [21]) imply a large-scale rearrangement within the
plane of the interfacial layer and in the direction orthogonal
to it. It is intuitive that conformational (motional) flexibility
of the membrane-bound channel domain and significant
freedom of motion in the membrane interfacial layer and
bilayer are prerequisites for the cooperative motion required
for protein insertion and voltage-gated channel activation
from the initial surface-bound state. Conformational free-
dom is implied by:
(a) Reversible thermal melting and change of inter-residue
distances detected by FRET of membrane-bound P178 [21].
The ability of the protein to undergo large internal distance
changes as a function of temperature without denaturation is
presumably a consequence of its restricted degrees of en-
tropic freedom in two-dimensional space.
(b) Rapid and extensive H/D exchange of P190 bound to
liposomes [25].
(c) The reversible thermally induced increase of inter-
residue distances is prevented at values of the membrane
surface potential, wo, more negative than  60 mV, or
anionic lipid concentrations >30 mol% at 0.1 M ionic
strength, as is the ability of P178 to insert into the membrane
and form channels. Using different anionic lipid concentra-
tions and ionic strengths, channel formation and protein
insertion are remarkably precisely tuned at woc 60 mV
(Fig. 7; [26]). It was concluded that the motional freedom of
the surface bound P178 that is necessary for insertion and
channel formation is constrained by electrostatic interactions
of the positively charged basic groups of the cationic poly-
peptide with phosphates of the lipid headgroups (Fig. 8A).
(d) Motional flexibility of the membrane-bound channel
domain of colicin Ia was also demonstrated by solid state
NMR using liposomes with 25 mol% anionic lipid content
[27]. A significant increase in motional amplitudes for both
the backbone and side chains was shown on a pico- to
Fig. 5. (A) Far-UV circular dichroism and (B) FTIR spectra of soluble
(blue) and membrane-bound (red) colicin E1 channel domain. Liposomes
(0.1 Am) were prepared by extrusion of DOPG/DOPC, 2:3 mol/mol. The
data on a-helical content are shown in the inset. The FTIR spectra were
corrected for absorbance of side chains (modified from Ref. [21]).
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microsecond time scale. Motions on the microsecond time
scale could include independent (uncorrelated) small-scale
reorientations of helices in bilayer, rocking motions in and
out of the plane of the membrane bilayer. The 12–16j
angular excursion of the colicin Ia channel domain back-
bone, detected in this study, differs from the behavior of
bacteriorhodopsin and the phage fd coat protein. The
amplitudes of motion of the side chains upon membrane
binding increase even more than for the backbone. A high
mobility of lysine side chains of the membrane-bound
colicin E1 channel domain was previously shown by
solid-state NMR of the colicin E1 P190 [28].
2.3. No detectable molten globule intermediate
The intriguing suggestion that the low pH activity of the
colicin A channel domain might occur through an unfolded
molten globule intermediate in which the a-helix content is
preserved [29] is not supported by the data for colicin E1. In
principle, the exposure of the hydrophobic core in molten
globule would imply that this intermediate state would have a
larger affinity than the native water-soluble state for the lower
polarity membrane surface [30]. However, for the soluble
channel domain of colicin E1, P190, the active low pH state is
not accompanied by a loss of tertiary structure as monitored
by near-UV CD [31]. Furthermore, loss of tertiary structure
and conservation of secondary structure are necessary, but not
sufficient, determinants of the molten globule state. In addi-
tion, the molten globule preserves the compact hydrophobic
core [30]. The data show that the only unfolded intermediate
that can be detected in the interaction with membranes is
characterized by (i) a substantial increase (ca. 30%) in helical
content, as discussed above, which is required to convert the
soluble P178 to an integral trans-membrane channel; (ii) a
threefold increase in the membrane-subtended protein cross
section upon membrane binding as measured by surface
plasmon resonance [21]; (iii) Br- (unpublished data) and
Doxyl- [32] quenching of fluorescence of P190 shows that
tryptophans of hydrophilic helices are accessible to contact
with quenchers, implying that helices are deep in the inter-
facial layer parallel or oblique to the membrane plane, rather
than forming three-dimensional compact domain on the
membrane surface. It is possible to consider, however, that
the unfolding of the colicin that follows membrane binding
(30 s 1 < t1/2 < 10 s
 1) under the conditions described in
Section 2.1, occurs through a molten globule intermediate.
Such an intermediate would not be detected because of the
difficulty of measuring time-resolved near-UV CD changes
on a millisecond time scale.
2.4. The open channel state
2.4.1. Protein import is integral to voltage gating
Voltage-gated opening of the ion channel of the pore-
forming colicins is known to be mechanistically different
from that of the classical integral membrane channels.
Whereas gating of the latter involves small conformational
changes of the trans-membrane segments [33], gating of
colicin channels involves import of a large part of the
protein from the membrane surface into and across the
Fig. 6. Sequence of events in membrane import of the colicin channel
domain. (A) Surface-bound globular non-inserted P178 [13], which
preserves most of the interhelix contacts of the soluble state. This could be
the intermediate state for a surface potential, AwoAb60 mV as a result of
incomplete unfolding of surface-bound P178. (B) An extended two-
dimensional helical array in the membrane interfacial layer as a precursor
to the open channel state for woc 60 mV; this helical array is less flexible
and more compact at AwoAH 60 mV. (C) Depiction of the imported open-
channel state; comparison with (B) shows requirement for movement of
surface-bound helices in the transition from closed to open channel states.
Hydrophobic helices VIII and IX are drawn in brown, and hydrophilic and
partially amphipathic helices are in blue.
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hydrophobic core of the bilayer [18,34]. As discussed
above, this large-scale import is the underlying cause of
the requirement for conformational flexibility of the surface-
bound closed channel intermediate. Much information on
the qualitative structural nature of the inserted channel has
come from a series of experiments using cis- and trans-side
streptavidin trapping of biotin-labeled single cysteine
mutants of the 177 residue colicin Ia C-terminal channel
domain studied in planar lipid bilayers [35]: (i) Using the
colicin Ia C-terminal domain that was biotin-labeled at the
apex (residue 594) of the helix VIII–IX hydrophobic hair-
pin, this system has provided the only definite proof for a
voltage-independent trans-side penetration of the VIII–IX
hairpin [36]. It has not been possible to detect this trans-side
penetration using liposomes (Lindeberg, Zakharov, and
Cramer, unpublished data). Thus, trans-side penetration of
the hydrophobic hairpin may only involve a small fraction
of the colicin population at any one time, although all
molecules assume this state and are eventually trapped.
The voltage-gating event consists of the translocation to
the trans-side streptavidin-accessible domain, residues
Leu474–Tyr541, a very long 68-residue peptide segment
Fig. 8. Representative amphiphatic helical segments of channel-forming domain (A) in interfacial layer, and (B) inserted into membrane bilayer by a membrane
potential (voltage-gating) as an anti-parallel helical hairpin in the open-channel state. Trp shown inserted into membrane (A), to illustrate results of experiments
on quenching of colicin E1 Trp fluorescence [32]. Lysine side chains are shown to snorkel to the surface [70].
Fig. 7. Macroscopic steady-state current in planar bilayers as a function of surface potential calculated for using Gouy–Chapman theory [69]. Data were
normalized relative to the amplitude of the maximum current for different ionic strengths, i.e. at 25, 30, and 70 mol% DOPG for 0.1 ( and red), 0.3 ( and
green), and 1.0 M ( and blue) KCl, respectively.
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consisting of helices II–V in the soluble Ia channel peptide.
The translocated segment is bounded by up- and down-
stream trans-membrane helices, ca. residues Asn454–Leu474
and Tyr541–Arg560, upstream from the hydrophobic hairpin
anchor, Ileu574–Ileu612. Thus, including the bordering trans-
membrane helices, the biotin–streptavidin experiments
show that approximately 105 residues of the colicin Ia
channel domain can be imported across or translocated into
the membrane by the voltage-gated channel opening. In
addition, an additional nine-residue heme-agglutinin peptide
or highly charged FLAG (DYKDDDDK) can be trans-
located [34]. A partly corroborative result for the colicin
E1 channel domain was obtained using liposomes by differ-
ential labeling in the presence and absence of a potassium
diffusion potential [18]. Residues 420–460, corresponding
to colicin Ia residues 524–564, were inferred to reside in the
membrane inserted segment, and believed to include two
trans-membrane segments of Ia.
The question has been raised as to whether the trans-
location of the 68-residue segment of colicin Ia occurred
simultaneously or, because most trapping experiments were
done with single Cys mutants, the translocated loop and the
upstream trans-membrane helix might be variable, ‘‘the
spaghetti model’’ [37]. This alternate view was tested by
looking for cis-side streptavidin-trapping of biotin attached at
any one of many Cys residues inserted by site-directed
mutagenesis in the 68 residue translocated segment [18,35].
If the actual translocated segment was small, variable, and
time-dependent, a Cys residue in this region should be found
in the cis-side aqueous phase where it could be trapped. No
such Cys residues were found. However, if the Cys residue
flipped back only as far as the cis-side interfacial layer of the
membrane, then it would probably not be accessible to
streptavidin. The ‘‘spaghetti model’’ has been rendered
unlikely by recent data showing that a 134-residue hydro-
philic polypeptide inserted into colicin Ia can be transported
to the trans-side of the membrane bilayer [38].
2.4.2. Problem of translocation of charged residues; role of
helical hairpins and dipoles
Insertion of the colicin surface-bound helices into and
across the membrane bilayer as part of the voltage-gating
process confronts the large energy barrier (the Born energy,
40 kcal/mol for the singly charged terminal ionic group of
lysine with a 2.0-A˚ radius [39]) associated with translocation
of charged residues across the hydrophobic membrane
bilayer. As noted above, it is energetically favorable for
helical units on the membrane surface to be organized on the
membrane surface as paired anti-parallel helical dipoles in
individual helical hairpins. Voltage-gated translocation of
helices II–VI of the colicin channel domain as helical
hairpin units (prototype inserted hairpin shown in Fig. 8B)
could reduce the energy barrier because of charge pairing
and neutralization of the some of the amino acid charges. The
68-residue translocated segment of helices II–Vof colicin Ia
contains 22 charged residues, 15 basic and 7 acidic.
2.4.3. Nature of the pore structure
The structure of the open channel is enigmatic, as
discussed more completely in a recent review [40]. A
fundamental problem, which ultimately leads to a structur-
ally difficult view of the channel, is that the channel from
the intact colicin or the pore-forming domain is monomeric
in planar bilayers. This is based on titration of ionic solute
efflux in liposomes [41] and of channel current in bilayers
[42]. For the intact colicin, the monomeric open channel is
proposed to consist of four trans-membrane helices, two of
which are contained in the hydrophobic anchor, and two that
are hydrophilic framing the large translocated domain [40].
It is difficult to understand how these four helices can form
a defined channel. Even more difficult to understand is the
inference that the upstream fourth trans-membrane helix
would be free on the trans-side for the channel domain, and
that the channel might then consist of only three trans-
membrane helices [34]. In spite of the historical emphasis
on single molecule action, it is possible that a significant
fraction of the active colicin channels in the planar bilayer,
particularly after long incubation times, is actually dimeric
or oligomeric.
2.4.4. Caveats to in vitro experiments with synthetic lipid
membranes
It is obvious that in the attempt to utilize a pure and
spectroscopically tractable system to study protein–mem-
brane interactions, it is quite possible for artifacts to be
introduced. A general caveat in a study of protein insertion
into artificial membranes is the absence of the membrane
proteins that certainly direct the insertion under physiolog-
ical conditions. On the other hand, the lipid membrane
environment is known to define or influence many proper-
ties of integral membrane proteins: (i) the thickness of the
bilayer dictates the length of trans-membrane a-helical or h-
sheet segments; (ii) the polarity or dielectric constant of the
membrane and interfacial layer is a determinant of the trans-
membrane distribution of hydrophobic and hydrophilic
residues and, together with steric factors, that of tryptophan
[43]; (iii) the existence of the negative membrane surface
potential is the simplest explanation of the ubiquitous cis-
positive distribution of positively charged residues [39].
Another possible in vitro caveat in studies of the inter-
action of artificial membranes with pore-forming colicins is
the use of acidic pH to initiate the interaction. The use of
acidic pH in studies of the membrane interaction of toxin,
fusion, and colicin proteins and peptides in vitro is a
conceptually well-established method for initiating the
interaction of these membrane-active proteins with anionic
lipid membranes. The electrostatic interaction between the
anionic membrane and the cationic polypeptide generated at
low pH replaces to some extent the specific protein inter-
actions in vivo that initiate the interactions. There is no
question about the physiological relevance of this procedure
for toxin and fusion proteins such as diphtheria that pass
through the acidic endosomal compartment. In planar mem-
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brane experiments, the behavior of the colicin channel
domain is qualitatively similar to the T domain of diphtheria
toxin. In experiments with intact colicin, one other conse-
quence of the use of acidic pH is that unfolding is facilitated
[44], apparently because the interaction of the C domain
with R and T domains is destabilized [4].
2.4.5. Membrane thinning
The binding and insertion into the membrane interfacial
layer of small membrane-active peptides, such as the 23-
residue peptide, magainin-2, causes thinning of synthetic
lipid bilayers, measured by lamellar X-ray diffraction, which
can facilitate spontaneous peptide insertion [45]. Bilayer
thinning is 1 A˚ at a peptide/lipid molar ratio of 1:100 and 2
A˚ at 1:60. This effect could be relevant in liposome experi-
ments with colicin channel peptide. On one hand, the
channel peptide/lipid ratio is smaller, typically 1:500 [21];
however, the amino acid/lipid molar ratio is probably similar
to that for magainin. Protein-induced membrane thinning is
probably not a factor in planar bilayer experiments where
protein/lipid ratios are small.
2.4.6. Mechanism of action of immunity protein; implica-
tions for formation and structure of open channel state in
vivo
Colicin-producing cells protect themselves by coordinate
but not stoichiometric production of an immunity protein
that inhibits very specifically the cognate colicin to block its
lethal effect. The immunity proteins for the channel-forming
colicins, small hydrophobic proteins consisting of three
(colicin E1) or four (colicin A) trans-membrane helices,
are localized in the cytoplasmic membrane [10,46] and
interact with the C-terminal channel-forming domain
[10,47,48]. The use of hybrid colicins to identify regions
of immunity [47,48], and co-immunoprecipitation of the
helical hairpin with the colicin A immunity protein [11],
show that helix VI, the helix VII–VIII interface, and the
helix VIII–IX hairpin of the C-terminal domain are crucial
for channel formation. These are exactly the same regions of
the channel domain that have been shown to be the trans-
membrane segments mapped by differential hydrophobic
labeling in liposomes [18] and biotin–streptavidin trapping
in planar bilayers [34,35]. A model for the mechanism of
interaction of the hydrophobic helices of the colicin E1
immunity protein with the colicin channel domain has been
presented elsewhere (Fig. 8 in Ref. [49]).
3. Colicin import across the outer membrane and
periplasm
Receptor-mediated protein import; the two receptor
concept; function of T domain in translocation across outer
membrane. The existence of two well-defined outer mem-
brane proteins, BtuB and TolC, for cellular import of colicin
E1 provides a framework for considering its receptor-medi-
ated uptake mechanism. In addition to the R domain that
contains the sequence information for binding to the BtuB
receptor, the colicin E1 T-domain also contains a binding
site for the unique outer membrane TolC protein (Fig. 1D).
This suggests a two-receptor concept for uptake of this
particular colicin, somewhat analogous to the two receptor
concept for cellular uptake of HIV [50] and the possibilities
for dual or multiple receptor function in signal transduction
pathways [51]. For HIV, the gp120 envelope glycoprotein
can interact with the CD4 receptor on the surface of target
cells such as T lymphocytes. The binding to CD4 can
induce conformational changes in gp120 that lead to expo-
sure, recognition, or formation of a chemokine co-receptor.
3.1. Import of colicin E1
The data suggest a two-receptor model for colicin E1.
The vitamin B12 receptor, BtuB, can function in initial
recognition and binding, and TolC as the second receptor in
channel-mediated protein uptake (Figs. 9). The 140-residue
TolC binding domain is located in the N-terminal third of
the colicin E1 polypeptide (Fig. 1D), which has traditionally
been called the T or translocation domain. In this tradition,
the T and R domains, respectively, are responsible for
translocation across the periplasmic space and the outer
membrane. In fact, the functional definition of the T (trans-
location) domain involves translocation across both the
outer membrane and the periplasmic space, a definition
distinct from the traditional view in which the three struc-
turally definable colicin domains (R, T, and C) functioned in
the three definable compartments of the cell envelope, outer
membrane, periplasm, and cytoplasmic membrane, respec-
tively.
3.2. The second receptor for colicin E1
The unique 100-A˚ extended 12-stranded antiparallel
trimeric helical barrel structure of the TolC outer membrane
protein has a 35-A˚ internal diameter channel that extends
nearly through the 100-A˚ length [52], and therefore across
most of the ca. 150-A˚-wide periplasmic space. This wide
channel tapers to a narrow opening on its periplasmic end,
which might restrict the passage of a polypeptide substrate.
However, because TolC is known to be utilized for the
cellular export of large proteins (ca. 170 kDa) in type I
secretion, it has been inferred that the tapered end of the
trimeric helical barrel structure must open to allow passage
of protein substrates that must be at least partially unfolded
[53]. This would also imply that colicin E1 can be trans-
located through this channel across the outer membrane into
the periplasmic space. Passage into the periplasm would
occur with the T domain transported first and the colicin C
domain translocated in a mostly unfolded state. This
requirement was also inferred from the loss of cytotoxicity
of disulfide cross-linked C domain of colicin A [54]. After
passing through TolC, further translocation would be driven
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by the function of TolA, which is not understood. The
literature implies that the requirement of TolC for trans-
periplasmic translocation among A-type colicins is unique
to colicin E1. In this respect, it is of interest that colicin E1
is also unique among these colicins (E1, E2, E3, A, K, and
N) in remaining mostly active with respect to cytotoxicity
when 234 residues were deleted (TolADM54–A287) from
the 421-residue TolA protein [55]. This implies that when
the trans-periplasmic TolC is used for colicin translocation
from the outer membrane, TolA does not have to span the
periplasm from the cytoplasmic membrane in order to
participate in translocation. TolA must direct further trans-
location through TolC, which ultimately must include trans-
fer of the C domain that will interact with the TolQ,R
Fig. 9. Two-receptor concept: BtuB and Tol C outer membrane proteins used for uptake of colicin E1. X-ray crystal structures of colicin E3 [2], FepA [71], and
TolC [52] were used to model the initial recognition of colicin E3 by BtuB, and its proposed subsequent interaction with TolC in the E. coli outer membrane.
The BtuB outer membrane receptor is shown as a modified (N-terminal ‘‘plug’’ segments 59–70 and 96–117 deleted) structure of the FepA receptor [71],
based on its sequence identity and significant structure homology with BtuB.
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translocation proteins embedded in the cytoplasmic mem-
brane. The trypsin-reversal phenomenon in which trypsin
added to the cellular exterior can reverse inhibition of active
transport by the C domain inserted into the cytoplasmic
membrane [8,56,57] implies that part of the colicin E1
molecule, presumably the R domain, remains in the exterior
of the outer membrane while the channel domain acts to
depolarize the cytoplasmic membrane. As it has been
proposed that the opening of the distal end of the TolC
channel involves a twisting of the a-helical barrel [52], it
may be speculated that one active function of the R domain
at the exterior is to unwind the extended coiled-coil in order
to generate the ‘‘open state’’ of the distal end of the TolC
channel.
3.3. Function of the first receptor
In the two-receptor model for colicin import through the
outer membrane, the primary BtuB receptor has two func-
tions: (i) initial binding and sequestering of the colicin. It
has been proposed that the initial interaction between colicin
E3 is hydrophobic, between the tip of the colicin R domain
and a hydrophobic region at the top of the plug domain of
BtuB [2]. However, this region is actually not very hydro-
phobic as it contains three basic residues within six residues
on either side of the M383–A384 turn. Electrostatic inter-
actions would seem appropriate for the initial attractive
interactions that must guide the R domain to the receptor
over large distances. (ii) It has been proposed [4] that the
function of the R-domain coiled-coil, which appears not to
be necessary for high affinity binding to the BtuB primary
receptor, is to unwind after binding to the primary receptor
and thus induce extensive or partial unfolding of the T and C
domains and their binding to, and entry into, the neighbor-
ing secondary TolC receptor-translocator (Fig. 10). The
energy required for unfolding could be derived in vitro
from the energy of binding to the receptor, and in vivo as
well from the proton electrochemical potential stored across
the cytoplasmic membrane.
3.4. One or two receptors for the other colicins?
The TolC protein has such a uniquely useful structure for
inter-membrane protein translocation and is used so ubiqui-
tously that one wonders why it is not required by more
colicins. A requirement for a second outer membrane protein
is not known for the B-group TonB-requiring colicin Ia, or for
the small A-group colicin N that uses OmpF. The minimum
channel aperture of the 16-stranded anti-parallel OmpF h-
barrel is 7 11 A˚ [58], which may not be large enough to
allow passage of an unfolded polypeptide. On one hand, a
role for OmpF in colicin translocation was implied by the
decrease in the OmpA aperture in a G119D colicin-resistant
mutant in loop L3 of OmpF [59,60]. On the other hand,
immobilization of the L3 loop by Cys–Cys cross-linking did
not cause a major decrease in the activity of colicins N and A
[61]. From these data and earlier data on an exterior location
of residues needed for colicin N/A cytotoxicity [62], it was
proposed that after binding to OmpF, these colicins cross the
outer membrane outside OmpF without using any Omp ([3];
also, see discussion in Ref. [40].)
The A-group colicins E3, E9, and A seem to require the
outer membrane protein, OmpF, in addition to BtuB. It has
been previously proposed that OmpF could act as a channel
to carry the unfolded T domain of colicin A across the outer
membrane to make contact with TolA [63]. A prediction of
the ‘‘two-receptor model’’ is that the ion channel size of the
OmpF proteins should be occluded by these colicins.
Preliminary experiments show discrete channel closing of
OmpF channels by colicin E3 (Eurokova, Zakharov, Rokit-
skaya, Antonenko, and Cramer, unpublished). It would be of
interest to study the OmpF–colicin interaction by site-
directed spin labeling, as was done in studies of the
interaction of colicin B with its FepA receptor [64].
Fig. 10. Scheme of colicin E1 import: (A) initial recognition of R domain by BtuB receptor; (B) unwinding of extended coiled-coil of R domain would result in
loss of domain interactions and partial unfolding of T-domain followed by its interaction with TolC; (C) TolA-mediated translocation of T-domain through TolC
to inner membrane. IM, OM, inner (cytoplasmic) and outer membrane (modified from Ref. [4]). Bent conformation of TolA is non-canonical relative to the
literature, and is based on its unique interaction with colicin E1 [55].
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3.5. The functional R domain of colicin E3
Colicin E3 [65], and 135- and shorter peptides derived
from its structurally defined R domain [5], bind to purified
BtuB receptor with a 1:1 stoichiometry and high affinity.
Far-UV CD and melting analysis show that the 135-residue
peptide has a high content of a-helical coiled-coil, similar to
the intact colicin E3. The helical coiled-coil content is
reduced in a 60-residue ‘‘partial R’’ peptide, but restored
upon binding. Thus, helical secondary and coiled coil
tertiary structures appear to be necessary for high affinity
binding. Growth of cells containing the BtuB receptor is
inhibited by a 76-residue peptide of the putative R domain
of colicin E9 [66] that has 92% sequence identity with the
135-residue R domain of colicin E3.
4. Epilogue
Based on the atomic structures of the pore-forming
colicins (Section 1), studies on channel formation and the
properties of the membrane-bound intermediate state carried
out with synthetic membranes (Section 2), and structure–
function of the outer membrane receptors and isolated R-
domain peptides (Section 3), one may speculate briefly
(and, of necessity, incompletely) on the in vivo pathway
of colicin channel insertion into the cytoplasmic membrane.
(i) The colicin binds tightly to a receptor whose major
function is recognition and binding, e.g., BtuB, for E-type
colicins. (ii) A second proximal receptor, e.g., Tol C, trans-
locates unfolded N- and C-terminal domains of colicin E1
across the outer membrane and most of the periplasmic
space. (iii) These receptors and the Tol or Ton/Exb system
may be concentrated in the region of inter-membrane
adhesion zones. (iv) Unfolding at the initiation of trans-
location through outer membrane receptors is driven by
unwinding of the R-domain coiled-coil. (v) The membrane
surface potential and the network of TolA/TolQ/TolR, or
TonB/ExbB/ExbD proteins mediate binding to the surface
of the cytoplasmic membrane of the C-terminal channel
domain in a conformationally flexible unfolded two dimen-
sional helical array. (vi) During the binding process, some
helical segments elongate to allow subsequent spanning of
the inner membrane. (vii) Insertion into the cytoplasmic
membrane is facilitated by conformational flexibility of the
colicin bound to the surface of the cytoplasmic membrane,
and specifically catalyzed by the integral membrane TolQ/
TolR or ExbB/ExbD proteins.
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